# The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects

> **NCT03734302** · PHASE1 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Brexpiprazole

## Key facts

- **NCT ID:** NCT03734302
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-24
- **Primary completion:** 2020-06-10
- **Final completion:** 2020-06-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734302, "The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03734302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*